In Epigenetic Regulation of Cancer, a series of volumes from the International Review of Cell and Molecular Biology series, various experts in epigenetics critically cover multiple facets of cancer-associated epigenetic alterations, including the impact of epigenetic deregulation in all steps of oncogenesis as well as promising strategies to therapeutically target cancer-associated epigenetic deregulation. This collection aims at expanding our knowledge on this exciting field of investigation and providing fresh insights as a basis for further investigations that will hopefully translate into an improved clinical management of patients with cancer.
- The collection provides accurate and critical review articles from invited experts on the selected topic
- Each review provides the newest insights and remarks on multiple subjects of the topic
- The volume offers a broad range of perspectives on detailed features
1. Epigenetic regulation of epithelial-mesenchymal transition during cancer development Sunisa Yoodee and Visith Thongboonkerd 2. Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis Sharath Mohan Bhat, Palla Ranga Prasad, and Manjunath B. Joshi 3. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Xodo, and Claudio Brancolini 4. Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma Monaza Adeeb, Lubna Therachiyil, Safwan Moton, Joerg Buddenkotte, Majid Ali Alam, Shahab Uddin, Martin Steinhoff, Aamir Ahmad 5. Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer Priti Roy, and Kamaleshwar P. Singh 6. Epigenetic inhibitors and their role in cancer therapy Nouha Abdelaziz, Lubna Therachiyil, Hana Sadida, Ateeque M. Ali, Omar S. Khan, Mayank Singh, Abdul Q Khan, Ammira Al-Shabeeb Akil, Ajaz A. Bhat, Shahab Uddin
Sheila Spada is at Weill Cornell Medical College, NY, USA Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.
Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
